Julius Bruch
Isaac Health said it raised $10.5 million in a Series A round led by local venture firm Flare Capital Partners, bringing total capital raised to $16.3 million and setting up a national push to scale its AI-driven memory clinic.
According to the company and investor statements, new backers Industry Ventures and New York-based Black Opal Ventures participated, while prior investors who participated included: New York’s Meridian Street Capital and Primetime Partners, and Manhattan Beach, Calif.-based B Capital. The funding is intended to expand partnerships with payers and health systems, and broaden a virtual model the company says is now available in all 50 states.
“On the growth front, we’ve added a number of new partnerships. We’ve really crystallized our go-to-market fit and strategy,” Isaac Health co-founder and CEO Julius Bruch told Fierce Healthcare. “We are squarely focused on health plans, both on Medicaid and Medicare primarily, but also covering health systems. That’s where we see really the strength of Isaac Health pay out the most.”
The raise comes amid a mounting public-health challenge, with the Alzheimer’s Association saying millions of older Americans live with Alzheimer’s and related dementias. Isaac Health says patients can face average waits of about three years for specialist appointments. The delays, the company argues, cost critical intervention windows, and increase emergency and hospital use.
“Our health system isn’t equipped for the scale and complexity of these needs,” said Dr. Joel Salinas, Isaac Health’s chief medical officer and co-founder.
Isaac Health positions itself as a neurologist-led, AI-enabled platform that combines remote screening, assessment, treatment and care management. The company claims patented screening algorithms and predictive machine learning can detect diverse cognitive conditions.
In a pilot study, Isaac Health reports that 73% of patients showed improved neurocognitive function at six months and 92% met short-term cognitive improvement goals within three weeks. The study has not been peer reviewed.
Flare Capital said its investment is a bet on scaling virtual neurology and driving return through better diagnosis and management, particularly as disease-modifying Alzheimer’s therapies enter clinical practice and payers seek value-based care solutions.
Isaac Health plans to use the new fund to improve virtual care infrastructure, enhance AI-driven detection and predictive clinical decision support, and to measure outcomes and optimize care pathways. The strategy mirrors broader market moves to combine digital-first care delivery with specialty expertise to shrink geographic and socioeconomic access gaps.